Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elanco Animal HealthMEX:ELAN 66 PB Ratio is 1.67 as of Jul. 14, 2026, which is 8% above its 10-year median of 1.55. GuruFocus rates MEX:ELAN with a GF Score™ of 66/100 and a GF Value™ of MXN243.25. The stock has 5 warning signs investors should review. Among 921 Drug Manufacturers companies, Elanco Animal Health ranks worse than 50.27% on this metric.
Elanco Animal Health Inc stock PB Ratio (=1.93) is close to 3-year high of 2.
The historical rank and industry rank for Elanco Animal Health's PB Ratio or its related term are showing as below:
MEX:ELAN'
s PB Ratio Range Over the Past 10 Years
Min: 0.55 Med: 1.55 Max: 2.45
Current: 1.93
During the past 11 years, Elanco Animal Health's highest PB Ratio was 2.45. The lowest was 0.55. And the median was 1.55.
MEX:ELAN's PB Ratio is ranked worse than 50.27% of 921
companies
in the Drug Manufacturers industry
Industry Median: 1.9
vs MEX:ELAN: 1.93
During the past 12 months, Elanco Animal Health's average Book Value Per Share Growth Rate was 1.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -5.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -6.90% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Elanco Animal Health was 3.70% per year. The lowest was -11.10% per year. And the median was -6.30% per year.
Back to Basics: PB Ratio
Elanco Animal Health (MEX:ELAN) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Elanco Animal Health PB Ratio Related Terms
Elanco Animal Health PB Ratio Historical Data
* Premium members only.
The historical data trend for Elanco Animal Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Elanco Animal Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elanco Animal Health PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Elanco Animal Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where Elanco Animal Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Elanco Animal Health (MEX:ELAN) has a PB Ratio of 1.67 as of Jul. 14, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Elanco Animal Health and its competitors. This is near median its historical median of 1.55. Over the past decade, Elanco Animal Health's PB Ratio has ranged from 0.55 to 2.45. According to the industry distribution chart, Elanco Animal Health ranks #463 out of 921 companies in the Drug Manufacturers industry, placing it in the top 50.3%.
Is Elanco Animal Health's PB Ratio too high?
Elanco Animal Health's current PB Ratio of 1.67 is near median its 10-year median of 1.55. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 2.45. The Drug Manufacturers industry median PB Ratio is 1.90. Elanco Animal Health's value of 1.67 is 12.1% below this industry median. Based on the distribution chart, Elanco Animal Health ranks #463 out of 921 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Elanco Animal Health has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Elanco Animal Health's PB Ratio compare to ALKS and HIMS?
According to the Drug Manufacturers industry distribution chart, Elanco Animal Health ranks #463 out of 921 companies for PB Ratio. This places Elanco Animal Health in the lower half of its industry. The industry median PB Ratio is 1.90. Elanco Animal Health's value of 1.67 is 12.1% below this benchmark. Historically, Elanco Animal Health's own PB Ratio has ranged from 0.55 to 2.45 over the past decade. While the company's 10-year median is 1.55 vs. the industry median of 1.90, Elanco Animal Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.90, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elanco Animal Health's current PB Ratio of 1.67 is 12.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Elanco Animal Health and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elanco Animal Health's current PB Ratio is 1.67, which is near median its own 10-year median of 1.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elanco Animal Health stock overvalued right now?
Elanco Animal Health (MEX:ELAN) has a current PB Ratio of 1.67. The stock's GF Value™ is MXN243.25, compared to a current price of MXN392.00 — trading 61.2% above its estimated fair value. The current PB Ratio is 1.67, which is near median its 10-year median of 1.55 and 12.1% below the Drug Manufacturers industry median of 1.90. Elanco Animal Health's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Elanco Animal Health (MEX:ELAN), the current PB Ratio is 1.67 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elanco Animal Health (MEX:ELAN) Overvalued in 2026?
Based on GuruFocus' analysis, Elanco Animal Health stock appears to be overvalued.
The current stock price of MXN392.00 is trading 61.2% above its estimated GF Value™ of MXN243.25.
Key valuation signals for MEX:ELAN:
PB Ratio: 1.67 (near median its 10-year median of 1.55)
GF Value™: MXN243.25 vs. price of MXN392.00 (61.2% above fair value)
Industry Position: 12.1% below the Drug Manufacturers median (#463 of 921)
No single metric tells the full story. See the MEX:ELAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
66GF Score
Get the complete analysis for MEX:ELAN
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ELAN has been successfully added to your 
